Transfer and expression of recombinant nitric oxide synthase genes in the cardiovascular system

Author： Chen A.F.Y.   O'Brien T.   Katusic Z.S.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.19, Iss.7, 1998-07, pp. : 276-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Bradykinin in the Regulation of Endothelial Nitric Oxide Synthase Expression by Cardiovascular Drugs

By  

Current Pharmaceutical Design, Vol. 23, Iss. 40, 2018-02 ,pp. : 6215-6222

Bentham Science Publishers

Access to resources Recommend Favorite

Nitric oxide synthase inhibitors with cardiovascular therapeutic potential

By Hansen Jr. D.W.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 5, 1999-05 ,pp. : 537-547

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular effects of noradrenaline in hypovolemic haemorrhage: role of inducible nitric oxide synthase

By Tabrizchi R.  

European Journal of Pharmacology, Vol. 361, Iss. 2, 1998-11 ,pp. : 227-234

Elsevier

Access to resources Recommend Favorite

Roles of Cardiovascular Risk Factors in Endothelial Nitric Oxide Synthase Regulation: An Update

By  

Current Pharmaceutical Design, Vol. 20, Iss. 22, 2014-05 ,pp. : 3563-3578

Bentham Science Publishers

Access to resources Recommend Favorite

The inhibition of isoforms of nitric oxide synthase: non-cardiovascular aspects

By Pitzele B.S.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 5, 1999-05 ,pp. : 549-556

Informa Healthcare

Access to resources Recommend Favorite